Health Policy
NMQF Announces 2026 “40 Under 40 Leaders in Minority Health” Honorees
Quick Answer: What is the NMQF “40 Under 40 Leaders in Minority Health” award?
The National Minority Quality Forum’s annual 40 Under 40 program rec...
- Victor Mejia
FDA begins to draw the line on AI chatbots in healthcare
The Food and Drug Administration is moving from broad discussion to real-world oversight of AI chatbots in healthcare, and that shift is becoming m...
- Subash Kafle
What Are the 27,000 Blue Flags on the National Mall? The Meaning Behind the 'United in Blue' Display
Over 27,000 blue flags now cover the National Mall in Washington, D.C.. This massive visual display marks a growing health emergency across the Uni...
- Victor Mejia
Lower Prices for Wegovy and Ozempic — Will You Pay Less?
Novo Nordisk has announced plans to lower the U.S. list prices of Wegovy, Ozempic, and the oral GLP-1 medicine Rybelsus to $675 per month beginning...
- Subash Kafle
How the Inflation Reduction Act Could Affect Drug Innovation, Biosimilars, and Patient Access
WASHINGTON — The Inflation Reduction Act (IRA), passed in 2022, changed the way the federal government handles prescription drug prices. The law al...
- Victor Mejia
The Fight to Protect Black Women from Toxic Hair Products
A petition calling for stronger federal regulation of hair and beauty products marketed to Black women is gaining traction as public health advocat...
- Jessica Wilson
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
